Results 121 to 130 of about 2,396 (168)

Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.

Arthritis & Rheumatism, 2005
E. Kruithof, L. De Rycke, J. Roth, H. Mielants, F. E. Van den Bosch, F. de Keyser, E. Veys, D. Baeten   +7 more
semanticscholar   +1 more source

Late-Onset Ankylosing Spondylitis and Related Spondylarthropathies

Drugs & Aging, 2005
E. Toussirot, D. Wendling
semanticscholar   +1 more source

Spondylarthropathies

2011
Beth L. Jonas, Robert A.S. Roubey
openaire   +1 more source

[Inflammation in spondylarthropathies].

Revue du rhumatisme et des maladies osteo-articulaires, 1989
The inflammation seen in spondyloarthropathy has very distinctive features; it is preferentially located at the sites of attachment of muscle or ligament to bone, where ectopic ossification occurs; it particularly affects men, and usually starts after growth has ended; phagocytes clearly predominate over lymphocytes at sites of inflammation ...
openaire   +1 more source

MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes.

Arthritis & Rheumatism, 1998
N. Tsuchiya, M. Shiota, S. Moriyama, A. Ogawa, M. Komatsu-Wakui, H. Mitsui, D. Geraghty, K. Tokunaga   +7 more
semanticscholar   +1 more source

[Spondylarthropathies in children].

La Revue du praticien, 1995
The term juvenile spondylarthropathy is used for all the inflammatory articular diseases beginning before the age of 16 years and associating peripheral arthritis, enthesiopathy and sometimes spinal involvement, cutaneous or enteric manifestations. The disease occurs more often in boys (85% of cases) between the age of 10 and 12 years. A family history
openaire   +1 more source

Serum levels of interleukin 1-β, tumor necrosis factor-α, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies

Rheumatology International, 2004
E. Toussirot, P. Lafforgue, J. Boucraut, P. Despieds, A. Schiano, D. Bernard, P. Acquaviva   +6 more
semanticscholar   +1 more source

Seronegative Spondylarthropathie

Hospital Practice, 1979
openaire   +3 more sources

Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies

Expert Opinion on Pharmacotherapy, 2005
Daniel Wendling, Eric Toussirot
exaly  

Overlapping peptide-binding specificities of HLA-B27 and B39: evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies.

Arthritis & Rheumatism, 1999
Y. Sobao, Naoyuki Tsuchiya, Masafumi Takiguchi, Katsushi Tokunaga   +3 more
semanticscholar   +1 more source